VEGFA and dopa-responsive dystonia due to sepiapterin reductase deficiency: Of the 15 eyes with SRD, 12 eyes received intravitreal injection of an anti-vascular endothelial growth factor (anti-VEGF) agent at least once, and the treatment outcomes are summarized in Table 4.